Apellis Pharmaceuticals Inc (APLS) USD0.0001
0.96%- This stock can be held in a
Stocks and Shares ISASell:$17.57
Buy:$17.65
Change:
$0.10
(0.57%)
$0.10
(0.57%)Prices delayed by at least 15 minutes
Sell:$17.57
Buy:$17.65
Change:$0.10
(0.57%)
$0.10
(0.57%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 17 March 2025 | James George (Jim) ChopasChief Accounting Officer | Sell Tax related | 183 | $24.82 | $4,542.74 | 47,955 |
| 5 March 2025 | David O WatsonGeneral Counsel | Sell Regular sell transaction (market) | 5,569 | $25.10 | $139,789.14 | 138,730 |
| 11 February 2025 | Mark Jeffrey DeLongChief Level Officer | Sell Tax related | 363 | $28.54 | $10,359.58 | 83,945 |
| 29 January 2025 | Pascal DeschateletsPresident | Sell Tax related | 826 | $29.52 | $24,386.49 | 1,147,716 |
| 29 January 2025 | Cedric G FrancoisChairman/CEO | Sell Tax related | 2,824 | $29.52 | $83,374.65 | 415,695 |
| 29 January 2025 | David O WatsonGeneral Counsel | Sell Tax related | 695 | $29.52 | $20,518.90 | 144,299 |
| 29 January 2025 | Timothy Eugene (Tim) SullivanCFO | Sell Tax related | 546 | $29.52 | $16,119.89 | 128,665 |
| 29 January 2025 | Mark Jeffrey DeLongChief Level Officer | Sell Tax related | 365 | $29.52 | $10,776.11 | 84,308 |
| 29 January 2025 | Adam J TownsendChief Level Officer | Sell Tax related | 695 | $29.52 | $20,518.90 | 84,050 |
| 29 January 2025 | Nur NicholsonCTO | Sell Tax related | 825 | $29.52 | $24,356.97 | 83,664 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 8 May 2024 | Pascal DeschateletsPresident | Sell Option/Award related | 56,335 | $42.15 | $2,374,542.78 | 1,138,555 |
| 21 June 2024 | EPIDAREX CAPITAL PARTNERS LLCVenture Capital | Sell Regular sell transaction (market) | 35,305 | $39.22 | $1,384,662.10 | 138,693 |
| 16 September 2024 | EPIDAREX CAPITAL PARTNERS LLCVenture Capital | Sell Regular sell transaction (market) | 29,476 | $36.09 | $1,063,788.84 | 107,524 |
| 8 May 2024 | Pascal DeschateletsPresident | Sell Option/Award related | 22,472 | $42.85 | $962,902.73 | 1,116,083 |
| 22 January 2025 | Cedric G FrancoisChairman/CEO | Sell Tax related | 13,551 | $30.43 | $412,295.95 | 418,519 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.